Fresh from the biotech pipeline--2012: FDA approvals hit a new high mark in 2012, with a December flurry of approvals. Orphan and fast-track drugs showed strong in the list Randy Osborne reports

Saved in:
Bibliographic Details
Published in:Nature biotechnology 2013-02, Vol.31 (2)
Main Author: Osborne, Randy
Format: Article
Language:English
Subjects:
Biotechnology industry
Drugs
Licensing, certification and accreditation
Pharmaceutical industry
Product development
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1087-0156
1546-1696